LAURA TALAKKOTTUR: Open Payments
NPI 1275787681 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,801 in 97 payments from 24 companies in 2025. Trend: 2023 $206 · 2024 $310 · 2025 $1,801
Food & beverage: $1,801
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $243 |
| Novo Nordisk Inc | 11 | $224 |
| ABBVIE INC. | 12 | $216 |
| PFIZER INC. | 14 | $159 |
| Lilly USA, LLC | 3 | $154 |
| Exact Sciences Corporation | 7 | $141 |
| Dynavax Technologies Corporation | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| GlaxoSmithKline, LLC. | 3 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
Products named: OTEZLA, VRAYLAR, ZEPBOUND, Wegovy, The Cologuard Plus Collection Kit, Heplisav-B, AIRSUPRA, ELIQUIS.
Industry payments across FL — which companies pay providers there.
